Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment

Immunobiology

Volumn 208, Issue 4, 2003, Pages 413-422

  von Aulock, Sonja ^a   Morath, Siegfried ^a   Hareng, Lars ^a   Knapp, Sylvia ^b   van Kessel, Kok P M ^c   van Strijp, Jos A G ^c   Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CD14 ANTIGEN; CHEMOATTRACTANT; COMPLEMENT COMPONENT C5A; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOTEICHOIC ACID; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE RELEASE; FEMALE; GRAM POSITIVE BACTERIUM; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATION; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0347126573     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00285     Document Type: Article

References (19)

1. Bulut Y, Faure E, Thomas L, Equils O and Arditi M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167: 987-994.
2. Deininger S, Stadelmaier A, Von Aulock S, Morath S, Schmidt RR and Hartung T. 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170: 4134-4138.
3. Gao JJ, Xue Q, Zuvanich EG, Haghi KR and Morrison DC. 2001. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun. 69: 751-757.
4. Ginsburg I, Fligiel SE, Ward PA and Varani J. 1988. Lipoteichoic acid-antilipoteichoic acid complexes induce superoxide generation by human neutrophils. Inflammation 12: 525-548.
5. Haziot A, Hijiya N, Gangloff SC, Silver J and Goyert SM. 2001. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. J. Immunol. 166: 1075-1078.
6. Hermann C, Spreitzer I, Schroder NW, Morath S, Lehner MD, Fischer W, Schutt C, Schumann RR and Hartung T. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32: 541-551.
7. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S and Hartmann G. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
8. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE and Finberg RW. 2002. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100: 1860-1868.
9. Kusunoki T, Hailman E, Juan TS, Lichenstein HS and Wright SD. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182: 1673-1682.
10. Lehner MD, Morath S, Michelsen KS, Schumann RR and Hartung T. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166: 5161-5167.
11. Lichtenberger C, Zakeri S, Baier K, Willheim M, Holub M and Reinisch W. 1999. A novel high-purity isolation method for human peripheral blood neutrophils permitting polymerase chain reaction-based mRNA studies. J. Immunol. Methods 227: 75-84.
12. Morath S, Geyer A and Hartung T. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
13. Morath S, Geyer A, Spreitzer I, Hermann C and Hartung T. 2002a. Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations. Infect. Immun. 70: 938-944.
14. Morath S, Stadelmaier A, Geyer A, Schmidt RR and Hartung T. 2002b. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640.
15. Opitz B, Schroder NW, Spreitzer I, Michelsen KS, Kirschning CJ, Hallatschek W, Zahringer U, Hartung T, Gobel UB and Schumann RR. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J. Biol. Chem. 276: 22041-22047.
16. Reglier H, Arce-Vicioso M, Fay M, Gougerot-Pocidalo MA and Chollet-Martin S. 1998. Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine 10: 192-198.
17. Sabroe I, Jones EC, Usher LR, Whyte MK and Dower SK. 2002. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168: 4701-4710.
18. Schneider O, Michel U, Zysk G, Dubuis O and Nau R. 1999. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology 53: 1584-1587.
19. Stuertz K, Merx I, Eiffert H, Schmutzhard E, Mader M and Nau R. 1998. Enzyme immunoassay detecting teichoic and lipoteichoic acids versus cerebrospinal fluid culture and latex agglutination for diagnosis of Streptococcus pneumoniae meningitis. J. Clin. Microbiol. 36: 2346-2348.